IL22 and colitis: The plant-derived indole, I3C, has been shown to bind to the aromatic hydrocarbon receptor (AhR) found in most tissues, including the gut [60] where it decreases colitis by reducing microbial dysbiosis and boosting the abundance of butyrate-producing Gram-positive bacteria in an IL-22–dependent way [61].